Information about Primary Pulmonary Hypertension and other forms of Severe Pulmonary Hypertension


PPH NEWS is an education-based resource site that provides information on the health issues surrounding Primary Pulmonary Hypertension (PPH), including what it is, the symptoms, diagnoses, and treatment options.
This website also provides resource to learn more about your legal rights and remedies if you or someone you know has developed PPH due to the use of diet drugs such as Fen Phen.

Get a FREE Evaluation

Select your state to
contact a PPH Lawyer

Diagnosing PPH

PPH is often missed during a normal medical examination because the symptoms, especially in the early stages, can be very subtle. As well, many of these symptoms can indicate medical problems that affect the heart and lungs other than Primary Pulmonary Hypertension. PPH is diagnosed only after several possible causes are excluded. Typically, additional tests are needed to positively diagnose PPH. It can often take up to three years from the time that the sufferer displays the earliest symptoms to the time that an accurate diagnosis can be made.

One of the ways to detect the presence of PPH is through an echocardiogram, which is an ultrasonic device that exams a patient's heart. The echocardiogram uses sound waves to measure the size and shape of the heart and surrounding tissues. An echocardiogram is an especially good idea for fen-phen users who may be at risk for PPH or heart valve defect.

Another way to detect for PPH is through the use of a catheter---a long, flexible, surgical tube that can be inserted into the body; for PPH it is placed near the heart in order to measure blood pressure. While an echocardiogram carries little or no risk, risks do exist with the catheter method, especially for those individuals who have weak hearts.

The prognosis for patients with PPH can cover a wide spectrum. Many patients who are able to make the appropriate changes in their lifestyle (diet, exercise, smoking, etc.) are still able to perform many of their day-to-day affairs. The median period of survival is three years after diagnosis, although the survival rate is generally longer for those patients without heart failure and for those patients diagnosed after 40.

If you have taken either fen-phen or Redux for more than three months and have any shortness of breath, chest pain or unusual fatigue, the Federal Drug Administration and the American Board of Cardiology recommend that individuals undergo an echocardiogram to detect for the possibility of medical problems.

 

SELECT YOUR STATE TO CONTACT A PPH LAWYER
Alabama Alaska Arizona Arkansas
California Colorado Connecticut Delaware
Florida Georgia Hawaii Idaho
Illinois Indiana Iowa Kansas
Kentucky Louisiana Maine Maryland
Massachusetts Michigan Minnesota Mississippi
Missouri Montana Nebraska Nevada
New Hampshire New Jersey New Mexico New York
North Carolina North Dakota Ohio Oklahoma
Oregon Pennsylvania Puerto Rico Rhode Island
South Carolina South Dakota Tennessee Texas
Utah Vermont Virginia Washington
Washington DC West Virginia Wisconsin Wyoming

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

top

Home

Legal Issues

PPH FAQ's

PPH Explained

Causes

Case

Injury

Settlement

Symptoms

Diagnosing PPH

Diagnosis

Treatment

Medications

Pulmonary Hypertension

What is Fen Phen

Problems Associated
with Fen Phen

Fen Phen and PPH

Fen Phen and Heart Disease

Fen Phen/Legal Rights

PPh Lawsuits

FDA Withdrawal

News

History

Links

 

Learn More About PPH Treatments:
» Remodulin
» Flolan
» Tracleer


Patients suffering from Primary Pulmonary Hypertension (PPH) caused by Fen-Phen, Pondimin or Redux are not included in the Nationwide Class Action Settlement Agreement with American Home Products.  PPH patients must file independent lawsuits to make legal claims.  To learn your legal rights, please contact us and speak with a PPH Lawyer for lawsuit information!